NOVO NORDISK A S (NVO)
Clinical trial NCT05424003 updates: 1. completion date: 2026-02-01 → 2026-08-01 2. primary completion date: 2026-02-01 → 2026-08-01
Clinical trial NCT05424003 updates: 1. completion date: 2026-02-01 → 2026-08-01 2. primary completion date: 2026-02-01 → 2026-08-01
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical